Issa Mohamed Khairie 4
4 · INCYTE CORP · Filed Jan 8, 2026
Insider Transaction Report
Form 4
INCYTE CORPINCY
Issa Mohamed Khairie
EVP, Head of US Oncology
Transactions
- Tax Payment
Common Stock
2026-01-06$106.66/sh−8,264$881,438→ 76,988 total - Sale
Common Stock
2026-01-07$109.07/sh−10,856$1,184,064→ 66,132 total
Footnotes (2)
- [F1]Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
- [F2]This includes an aggregate of 66,132 shares of common stock issuable pursuant to previously reported RSUs that have not vested.